The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document
  • No CSPEC related information was provided by the message!

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_000018.4:c.1966T>A

CA397726273

Gene: ACADVL (HGNC:37)
Condition: very long chain acyl-CoA dehydrogenase deficiency (MONDO:0008723)
Inheritance Mode: Autosomal recessive inheritance
UUID: 0a906e4f-b71a-403e-8791-eb24efee9601
Approved on: 2022-09-23
Published on: 2022-09-23

HGVS expressions

NM_000018.4:c.1966T>A
NC_000017.11:g.7225095T>A
CM000679.2:g.7225095T>A
NC_000017.10:g.7128414T>A
CM000679.1:g.7128414T>A
NC_000017.9:g.7069138T>A
NG_007975.1:g.10262T>A
NG_033038.1:g.14450A>T
ENST00000356839.10:c.1966T>A
ENST00000322910.9:c.*1921T>A
ENST00000350303.9:c.1900T>A
ENST00000356839.9:c.1966T>A
ENST00000542255.6:n.845T>A
ENST00000543245.6:c.2035T>A
ENST00000578033.1:n.391T>A
ENST00000578319.5:n.547T>A
ENST00000578711.1:n.1591T>A
ENST00000578809.5:n.538T>A
ENST00000579425.5:n.1082T>A
ENST00000583848.5:n.332T>A
ENST00000583850.5:n.737T>A
ENST00000583858.5:n.897T>A
NM_000018.3:c.1966T>A
NM_001033859.2:c.1900T>A
NM_001270447.1:c.2035T>A
NM_001270448.1:c.1738T>A
NM_001033859.3:c.1900T>A
NM_001270447.2:c.2035T>A
NM_001270448.2:c.1738T>A
More

Uncertain Significance

Met criteria codes 2
PM4 PM2_Supporting
Not Met criteria codes 3
PP4 PP3 PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.1966T>A variant in ACADVL is a stop-loss predicted to result in a 32-aa peptide extension at the C-terminus (PM4). This variant has been identified in one individual as a heterozygote identified by abnormal newborn screening results suggestive of very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency (PMID: 30194637). This study also showed reduced VLCAD activity in patient lymphocytes, however, this assay does not meet the requirements for use by the ClinGen ACADVL Variant Curation Expert Panel. This variant is absent from gnomAD v2.1.1 (PM2_Supporting).In summary, this variant meets the criteria to be classified as uncertain for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: (PM4, PM2_Supporting)
Met criteria codes
PM4
Additional 32-aa peptide at the C-terminus via stop-loss variant
PM2_Supporting
Not present in gnomAD
Not Met criteria codes
PP4
Reported as a heterozygote with WT. Residual enzyme activity is ~33%, not meeting PP4_moderate.
PP3
Available computational evidence does not provide predictions for this variant.
PM5
c.1968A>C is at the same codon, but is not LP or P
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.